Our results showed that HCC cells exhibited significantly lower levels of lipid accumulation when treated with increasing concentrations of verteporfin, suggesting that disrupting YAP-TEAD interactions could help utilizing lipid in HCC (Figure 6E, Figure S2K, p < 0.01). This evidence concerns the gene YAP1 and hepatocellular carcinoma.